Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure

Ruben R. de With; Michiel Rienstra; Harry J. G. M. Crijns; Isabelle C. Van Gelder; RACE 3 Investigators

doi:10.1007/s00392-019-01581-0

Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure

Ruben R. de With^*, Michiel Rienstra, Harry J. G. M. Crijns, Isabelle C. Van Gelder, RACE 3 Investigators

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	787-789
Number of pages	3
Journal	Clinical research in cardiology
Volume	109
Issue number	6
Early online date	29 Nov 2019
DOIs	https://doi.org/10.1007/s00392-019-01581-0
Publication status	Published - Jun 2020

Keywords

DIABETES-MELLITUS
RISK
OUTCOMES

Access to Document

10.1007/s00392-019-01581-0

Cite this

@article{0257acaf658b4d04821513990625be64,

title = "Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure",

keywords = "DIABETES-MELLITUS, RISK, OUTCOMES",

author = "\{de With\}, \{Ruben R.\} and Michiel Rienstra and Crijns, \{Harry J. G. M.\} and \{Van Gelder\}, \{Isabelle C.\} and \{RACE 3 Investigators\}",

note = "Funding Information: The study is supported by the Netherlands Heart Foundation (Grant 2008B035). Unrestricted grants from AstraZeneca, Bayer, Biotronik, Boehringer-Ingelheim, Boston Scientific, Medtronic, Sanofi-Aventis, St. Jude Medical paid to the Netherlands Heart Institute. The authors have nothing to disclose.",

year = "2020",

month = jun,

doi = "10.1007/s00392-019-01581-0",

language = "English",

volume = "109",

pages = "787--789",

journal = "Clinical research in cardiology",

issn = "1861-0684",

publisher = "Routledge/Taylor \& Francis Group",

number = "6",

}

TY - JOUR

T1 - Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure

AU - de With, Ruben R.

AU - Rienstra, Michiel

AU - Crijns, Harry J. G. M.

AU - Van Gelder, Isabelle C.

AU - RACE 3 Investigators

N1 - Funding Information: The study is supported by the Netherlands Heart Foundation (Grant 2008B035). Unrestricted grants from AstraZeneca, Bayer, Biotronik, Boehringer-Ingelheim, Boston Scientific, Medtronic, Sanofi-Aventis, St. Jude Medical paid to the Netherlands Heart Institute. The authors have nothing to disclose.

PY - 2020/6

Y1 - 2020/6

KW - DIABETES-MELLITUS

KW - RISK

KW - OUTCOMES

U2 - 10.1007/s00392-019-01581-0

DO - 10.1007/s00392-019-01581-0

M3 - Comment/Letter to the editor

C2 - 31784901

SN - 1861-0684

VL - 109

SP - 787

EP - 789

JO - Clinical research in cardiology

JF - Clinical research in cardiology

IS - 6

ER -